Andrew Ip

Hackensack University Medical Center — United States

Medicine · Health Sciences

17h-index1.5kcitations177works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(56), Lymphoma Diagnosis and Treatment(42), Cancer Genomics and Diagnostics(31), Cancer Immunotherapy and Biomarkers(16), COVID-19 Clinical Research Studies(14)

Publications177 total

Real-world outcomes after CAR T versus standard therapy in third-line or later relapsed or refractory follicular lymphoma in the United States.
PubMed·2026
The clinical applications of next-generation sequencing and ctDNA/cfDNA in lymphoma.
PubMed·2026
Cartiac: Comparative Cardiovascular Safety of CAR T Products for Non-Hodgkin’s Lymphoma – a Propensity Score–Matched International Multicenter Study
Transplantation and Cellular Therapy·2026
<scp>CD19 CAR</scp> T‐Cell Therapy in Primary Cutaneous Diffuse Large B‐Cell Lymphoma, Leg Type
American Journal of Hematology·2026Open Access
Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma
Blood·2025
Real-world outcomes of patients with relapsed refractory multiple myeloma treated with commercial bispecific T-cell engager antibodies: a single center experience
Leukemia & lymphoma/Leukemia and lymphoma·2025
Correlates and Detection of Digital Health Literacy in Patients With Colorectal Carcinoma or Non-Hodgkin Lymphoma: Cross-Sectional Study
JMIR Cancer·2025· 1 citedOpen Access
Developing artificial intelligence-based transcriptomic signature for the diagnosis of dark zone lymphoma in patients without MYC gene rearrangement
Blood·2025
Nivolumab with doxorubicin, vinblastine, and dacarbazine (NAVD) in older adults with classic Hodgkin lymphoma: Do S1826 results hold up in the real world?
Blood·2025Open Access
B- and T-cell clonality using peripheral blood cell-free RNA (cfRNA) in liquid biopsy
Blood·2025Open Access
Developing artificial intelligence-based transcriptomic signature for selecting patients with HOXA-MEIS1 pathway abnormalities for the treatment with menin inhibitors
Blood·2025Open Access
First-line salvage therapies in relapsed/refractory large B-cell lymphoma after second- or third-line CD19-directed CAR T-cell therapy
Blood·2025Open Access
Safety and efficacy of brexucabtagene autoleucel in elderly patients with relapsed or refractory Mantle Cell Lymphoma: A retrospective, multicenter, international study
Blood·2025
Long-term cardiovascular outcomes in patients with lymphoma who had early post-CAR-T cardiovascular events: A multi-center, international study
Blood·2025Open Access
The genetic landscape of lymphoma: Insights from a primary immunodeficiency NGS panel in lymphoma patients
Blood·2025Open Access
Developing transcriptomic signature for IDH1 and IDH2 acute leukemia and the demonstration of high prevalence of these signatures in mutation-negative leukemia
Blood·2025Open Access
Associations Between Anxiety or Depression Diagnosis and Immune Checkpoint Inhibitor Outcomes
Cancer Medicine·2025Open Access
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R
Haematologica·2025Open Access
Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Rituximab Plus Gemcitabine and Oxaliplatin in Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Match-Adjusted Comparative Analysis
Clinical Lymphoma Myeloma & Leukemia·2025Open Access
POSTER: ABCL-1119 Epcoritamab Plus Gemcitabine and Oxaliplatin Versus Glofitamab or Rituximab Plus Gemcitabine and Oxaliplatin in Patients With Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Match-Adjusted Comparative Analysis
Clinical Lymphoma Myeloma & Leukemia·2025
page 1 of 9Next →

Frequent Co-authors

André Goy(21), Andrew L. Pecora(16), Lori A. Leslie(11), Jaeil Ahn(8), Brittany Sinclaire(8), Stuart L. Goldberg(8), Maher Albitar(8), Michael Marafelias(7), Eric Hansen(7), Ihor S. Sawczuk(7), Michèle L. Donato(7), Roni Shouval(7), Alexandra Della Pia(7), Noa Biran(6), Urszula Bednarz(6), Hyung C. Suh(6), Tatyana Feldman(6), Michael Scordo(6), Miguel‐Angel Perales(6), Ronaldo C. Go(5)